London
· Delayed Price · Currency is GBP · Price in SEK BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of GBP 1.42 billion. The enterprise value is 1.38 billion.
| Market Cap | 1.42B |
| Enterprise Value | 1.38B |
Important Dates
The next estimated earnings date is Thursday, February 13, 2025.
| Earnings Date | Feb 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.68% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 52.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 21.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -80.52 |
| EV / Sales | 113.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -109.92 |
Financial Position
The company has a current ratio of 8.35, with a Debt / Equity ratio of 0.06.
| Current Ratio | 8.35 |
| Quick Ratio | 5.10 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.33 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.75% and return on invested capital (ROIC) is -15.18%.
| Return on Equity (ROE) | -22.75% |
| Return on Assets (ROA) | -13.70% |
| Return on Invested Capital (ROIC) | -15.18% |
| Return on Capital Employed (ROCE) | -26.26% |
| Revenue Per Employee | 118,225 |
| Profits Per Employee | -164,711 |
| Employee Count | 88 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.86% in the last 52 weeks. The beta is -0.25, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.25 |
| 52-Week Price Change | -7.86% |
| 50-Day Moving Average | 195.83 |
| 200-Day Moving Average | 190.09 |
| Relative Strength Index (RSI) | 63.47 |
| Average Volume (20 Days) | 4,843 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of GBP 12.30 million and -17.13 million in losses. Loss per share was -0.19.
| Revenue | 12.30M |
| Gross Profit | 5.64M |
| Operating Income | -18.83M |
| Pretax Income | -16.28M |
| Net Income | -17.13M |
| EBITDA | -17.45M |
| EBIT | -18.83M |
| Loss Per Share | -0.19 |
Balance Sheet
The company has 44.47 million in cash and 4.15 million in debt, giving a net cash position of 40.32 million.
| Cash & Cash Equivalents | 44.47M |
| Total Debt | 4.15M |
| Net Cash | 40.32M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 67.58M |
| Book Value Per Share | 0.76 |
| Working Capital | 64.09M |
Cash Flow
In the last 12 months, operating cash flow was -12.00 million and capital expenditures -547,529, giving a free cash flow of -12.55 million.
| Operating Cash Flow | -12.00M |
| Capital Expenditures | -547,529 |
| Free Cash Flow | -12.55M |
| FCF Per Share | n/a |
Margins
Gross margin is 45.85%, with operating and profit margins of -153.11% and -139.32%.
| Gross Margin | 45.85% |
| Operating Margin | -153.11% |
| Pretax Margin | -132.38% |
| Profit Margin | -139.32% |
| EBITDA Margin | -141.95% |
| EBIT Margin | -153.11% |
| FCF Margin | n/a |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.68% |
| Shareholder Yield | 0.68% |
| Earnings Yield | -1.21% |
| FCF Yield | -0.88% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |